Abstract:The devastating effects of COVID-19 have highlighted the importance of prophylactic and therapeutic strategies to combat respiratory diseases. Stimulator of interferon gene (STING) is an essential component of the host defense mechanisms against respiratory viral infections. Although the role of the cGAS/STING signaling axis in the innate immune response to DNA viruses has been thoroughly characterized, mounting evidence shows that it also plays a key role in the prevention of RNA virus infections. In this study, we investigated the role of STING activation during Influenza virus (IFV) infection. In both mouse bone marrow-derived macrophages and monocytic cell line THP-1 differentiated with PMA, we found that dimeric amidobenzimidazole (diABZI), a STING agonist, had substantial anti-IFV activity against multiple strains of IFV, including A/H1N1, A/H3N2, B/Yamagata, and B/Victoria. On the other hand, a pharmacological antagonist of STING (H-151) or the loss of STING in human macrophages leads to enhanced viral replication but suppressed IFN expression. Furthermore, diABZI was antiviral against IFV in primary air–liquid interface cultures of nasal epithelial cells. Our data suggest that STING agonists may serve as promising therapeutic antiviral agents to combat IFV.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to explore the antiviral effect of STING (stimulator of interferon genes) agonists during influenza virus (IFV) infection. Specifically, the study aims to evaluate whether STING agonists can inhibit the replication of multiple influenza virus strains by activating the host's innate immune response. ### Research Background and Problem Elaboration 1. **The Threat of Influenza Virus**: - Influenza virus is a negative - strand RNA virus, belonging to the Orthomyxoviridae family, mainly affecting the human respiratory system. - There are 5 million cases of severe diseases caused by influenza virus globally every year, and the death toll is as high as 650,000. Therefore, it is crucial to develop effective antiviral drugs to control influenza virus infection and diseases. 2. **The Mechanism of Action of STING**: - STING is a key innate immune component located in the endoplasmic reticulum and can be activated by binding to its ligand cyclic dinucleotide (CDNs). - The activation of STING can recruit and activate TANK - binding kinase 1 (TBK1) and other downstream factors, thereby inducing the expression of antiviral genes such as IFNs and interferon - stimulated genes (ISGs). - In addition, STING activation can also induce autophagy - related gene 5 (ATG5) - dependent autophagy, limiting the replication of certain RNA viruses. 3. **The Research Status of STING Agonists**: - The synthetic small - molecule STING agonist dimeric amidobenzimidazole (diABZI) has been found to have significant antiviral effects on multiple respiratory viruses, including SARS - CoV - 2, parainfluenza virus type 3, and human rhinovirus 16, etc. - However, the specific role of STING agonists during influenza virus infection has not been clarified yet. ### Research Objectives The objective of this study is to evaluate the antiviral effect of STING agonists in human or mouse macrophages and primary air - liquid interface - cultured nasal epithelial cells during influenza virus infection. Specifically: - **Verify the Antiviral Activity of STING Agonists**: Determine through experiments whether STING agonists can effectively inhibit the replication of multiple influenza virus strains (A/H1N1, A/H3N2, B/Yamagata, B/Victoria). - **Reveal the Mechanism of Action of STING Agonists**: Explore how STING agonists inhibit the replication of influenza virus by activating the host's innate immune response. - **Provide New Antiviral Strategies**: Provide theoretical basis and experimental support for the development of new antiviral drugs against respiratory viruses. In summary, this paper aims to reveal the potential therapeutic value of STING agonists by studying their antiviral effect during influenza virus infection and provide a scientific basis for the development of new antiviral drugs in the future.

Stimulator of Interferon Gene Agonists Induce an Innate Antiviral Response against Influenza Viruses

STING Agonist Induced Innate Immune Responses Drive Anti-Respiratory Virus Activity In Vitro with Limited Antiviral Efficacy In Vivo

Progress in innate immunity signaling molecule STING

Activation of toll-like receptor signaling pathway for protection against influenza virus infection

Innate immune pathway modulator screen identifies STING pathway activation as a strategy to inhibit multiple families of arbo and respiratory viruses

Characterization of a Novel Human-Specific STING Agonist that Elicits Antiviral Activity Against Emerging Alphaviruses

Stimulator of interferon genes (STING) inhibits coronavirus infection by disrupting viral replication organelles

An intranasal nanoparticle STING agonist protects against respiratory viruses in animal models

STING Strengthens Host Anti-Hantaviral Immunity Through an Interferon-Independent Pathway.

Potential antiviral activity of rhamnocitrin against influenza virus H3N2 by inhibiting cGAS/STING pathway in vitro

Discovery and Mechanistic Study of a Novel Human-Stimulator-of-Interferon-Genes Agonist

STING Agonists Induce an Innate Antiviral Immune Response Against Hepatitis B Virus.

Identification of new benzofuran derivatives as STING agonists with broad-spectrum antiviral activity

cGAS–STING‐mediated novel nonclassic antiviral activities

Agonist of stimulator of interferon genes as antitumor agents: a patent review (2008-2020)

The STING-MSR1 Axis Controls RNA Virus Infection Through Noncanonical Autophagy

Pharmacological activation of STING blocks SARS-CoV-2 infection

STING Orchestrates EV-D68 Replication and Immunometabolism within Viral-Induced Replication Organelles

Antiviral Activity of Influenza A Virus Defective Interfering Particles against SARS-CoV-2 Replication In Vitro through Stimulation of Innate Immunity

STINGing CD4+ T cells to induce refractoriness to HIV infection

Unique and complementary suppression of cGAS-STING and RNA sensing- triggered innate immune responses by SARS-CoV-2 proteins